Glutathione triggered degradation of polydopamine to facilitate controlled drug release for synergic combinational cancer treatment-Reference-Cited by-同舟云学术

Glutathione triggered degradation of polydopamine to facilitate controlled drug release for synergic combinational cancer treatment

Published:2019 Issue:43 Volume:7 Page:6742-6750
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Hao Ya-Nan¹²³⁴⁵,Zheng An-Qi¹²³⁴⁵,Guo Ting-Ting¹²³⁴⁵,Shu Yang¹²³⁴⁵^ORCID,Wang Jian-Hua¹²³⁴⁵^ORCID,Johnson Omar⁶⁷⁸,Chen Wei⁶⁷⁸^ORCID

Affiliation:

1. Research Center for Analytical Sciences

2. Department of Chemistry

3. College of Sciences

4. Northeastern University

5. Shenyang 110819

6. Departments of Physics

7. University of Texas at Arlington

8. USA

Abstract

Here we report a novel mechanism for triggering drug release in the polydopamine (PDA)-coated magnetic CuCo₂S₄ core–shell nanostructure by glutathione (GSH) triggered degradation of PDA for release.

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

U.S. Army Medical Research Acquisition Activity

National Institutes of Health

National Cancer Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2019/TB/C9TB01400D

Reference59 articles.

1. Functional Nanomaterials for Phototherapies of Cancer

2. Financial Hardships Experienced by Cancer Survivors: A Systematic Review

3. Hollow Copper Sulfide Nanosphere–Doxorubicin/Graphene Oxide Core–Shell Nanocomposite for Photothermo-chemotherapy

4. Mesoporous carbon nanoparticles capped with polyacrylic acid as drug carrier for bi-trigger continuous drug release

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cuproptosis-based nanomedicine suppresses triple negative breast cancers by regulating tumor microenvironment and eliminating cancer stem cells;Biomaterials;2025-02

2. Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe2+-doped nano-scaled metal–organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy;Journal of Colloid and Interface Science;2025-01

3. Cisplatin Encapsulated Plasmonic Blackbodies for NIR Light Activatable Chemo‐Phototherapy and Reduction of 4‐Nitrophenol;Chemistry – An Asian Journal;2024-09-06

4. Dual pH/redox-responsive size-switchable polymeric nano-carrier system for tumor microenvironment DTX release;Journal of Biomaterials Science, Polymer Edition;2024-06-30

5. Sol-gel synthesis, physicochemical characteristics and in vitro pH-responsive metformin drug release of uniformly polydopamine coated mesoporous silica nanospheres;Journal of Non-Crystalline Solids;2024-05